Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

La Ribonucleoprotein Domain Family, Member 1 (LARP1) (N-Term) Peptid

LARP1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN8104110
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für La Ribonucleoprotein Domain Family, Member 1 (LARP1) (N-Term) Peptid (ABIN8104110)

Target

LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))

Spezies

Human

Quelle

  • 7
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Verwendungszweck

    LARP1 Peptide - N-terminal region

    Sequenz

    MATQVEPLLP GGATLLQAEE HGGLVRKKPP PAPEGKGEPG PNDVRGGEPD
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Kommentare

    This is a synthetic peptide designed for use in combination with anti-LARP1 Antibody(ARP41077_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Buffer

    Lyophilized powder

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
  • Target

    LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))

    Hintergrund

    Background Information: LARP1 belongs to the LARP family and it contains 1 HTH La-type RNA-binding domain. The exact function of LARP1 remains unknown.

    Alternative Symbols: KIAA0731, LARP, MGC19556

    Molekulargewicht

    123kDa

    Gen-ID

    23367

    NCBI Accession

    NP_291029

    UniProt

    Q6PKG0
Sie sind hier:
Chat with us!